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Summary: Acetylcholinesterase levels were determined in cerebrospinal fluid and serum of 272 patients with
various neurological disorders. The patients were ordered in 13 diagnostic groups. The assay employed was
an antigen capture assay based on an immobilized monoclonal antibody selective for neuronal acetylcholin-
esterase (Rasmussen et al., Clin. Chim. Acta 166 (1987) 17-25 (1)).
In 100% of the cases the acetylcholinesterase levels in cerebrospinal fluid were 500—10000 fold higher than
expected for a regulär serum-derived protein (0.1 — 0.5%) at the intact blood-brain barrier. In both compart-
ments the test vahies showed w'ide variations, which were much greater in serum than in cerebrospinal fluid.
No specific relationship was discernible between the values obtained and any of the diagnostic groups,
although decreased levels of acetylcholinesterase were found in bacterial and viral meningitis, and elevated
levels were found in groups with more chronic diseases.
A possible transfer of acetylcholinesterase from cerebrospinal fluid to blood is discussed.
n o uc on superficial layers adjacent to the free cerebrospinal
The search for biochemical markers of brain destruc- fluid space, äs evidenced by the clearance of the car-
tion and disease in the circülating blood has been cinoembryonic antigen from deep parenchymal me-
unsuccessful so far (2). The extracellular space of tastases (4).
other organs, e. g. muscle and liver is open to the free ^ ̂  to serye ^ g markers ^ ̂
water compartment of the body whereas the blood-̂  ^ ^ bg of molecular masSj soluble
bram barner vutually blocks the direct transfer of jn g hages and slowl catabofized in the bod
protems m both direetions. The extracellular space of ^ ̂  the$e s acety,cholinesteraseJ) represents a
the central nervous System is thought to be cleared isi candidate> the more since chubb and co.
Via the cerebrospinal flmd compartment (3), bat it IS workers found ̂  ̂  acetylcholinesterase of the
conce,vable that this „sink functton is restncted to „„^^„j fluid is derived from central nervous
System (5).
J) Supported by the Deutsche Forschungsgemeinschaft, SFB Histochemical studies show acetylcholinesterase
2) ?rLnt address: K. Soerensen, Equichem Research Institute wi<*ely distributed in the brain, where it fills predom-
LTD, 393 Old Country Road, Carle Place, New York 11 514, inantly the extracellular space of several brain nuclei,
3 UiS.A. Q g nucleus caudatus, lentiformis, amygdalae, aocum-
) Aceffch'olinesterase (EC 3.1.1.7) bens' ventriculus anterior thalami and geniculatus la-
Butyryicholinesterase (EC 3.1.1.8) teralis (6).
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Acetylcholinesterase appears in the amniotic fluid of
fetuses with neural tube defects, obviously having
leaked from the early cerebrospinal fluid space (7).
Acetylcholinesterase, when measured, has to be dif-
ferentiated from the erythrocyte isoenzyme. As Ras-
m ssen and coworkers have obtained a monoclonal
antibody largely selective for the neuronal isoenzyme
(1), we were able to investigate the distribution of the
neuronal acetylcholinesterase in cerebrospinal fluid
and serum of a large number of patients.
Materials and Methods
Samples
Cerebrospinal fluid and blood samples were taken by lumbar-
and venipuncture respectively, from 272 patients with various
neurological disorders (151 males, 121 females; age r nge 17 to
78 years). For reference purposes, blood samples were drawn
from 9 healthy persons (students) aged about 25. The blood
samples were centrifuged after clotting for one hour. Blood and
cerebrospinal fluid samples were then frozen in aliquots at
-70°C.
Determinat ion of acetylcholinesterase
The immunoassay for determination of acetylcholinesterase was
exactly s described by Rasmussen et al. (1), who also reported
the accuracy, specificity and sensitivity of the assay. The mono-
clonal antibody 4F19 was employed in this study. Values pre-
sented are the average of three repeats.
Assay of blood-brain barrier function
Blood-brain barrier function was assayed according to 1. c. (8)
and (2) by determination of the albumin quotients (cerebrospL·
nal fluid: serum); an albumin quotient (Q χ l O3) > 5 indicates
blood-brain barrier impairment.
Results
Figure l shows the distribution of the test values of
cerebrospinal fluid and serum. Cerebrospinal fluid
values show a Standard distribution, whereas the dis-
tribution of the serum values is skewed towards the
lower values, including a considerable number of
measurements below the detection limit. Matrix and
methodical effects were ruled out by mixing experi-
ments (data not shown); see also I.e. (1). The rela-
tionship between the increasing serum values and the
increasing cerebrospinal fluid values is shown in
figure 2.
In figure 3, the 544 test values are presented in a Box-
and-Whisker Plot, which allows direct comparison of
values with skewed distribution. The patients are or-
dered in 13 diagnostic groups and a reference group
for serum values. There is a wide Variation of cere-
brospinal fluid and serum values in all groups. The
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Fig. 1. Distribution of acetylcholinesterase values of serum and
cerebrospinal fluid in arbitrary measurement classes
ranging from 0.1 - > 25 U/l. (l U = l μπιοί of sub-
strate hydrolysed per minute at 25 °C). Hatched bars,
serum; white bars, cerebrospinal fluid; < 0.1, Values
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Fig. 2. Acetylcholinesterase values of the sera of 272 patients
were plotted versus the corresponding values of the
cerebrospinal fluids. The dashed line represents y = ax
where a (1:4) is the quotient: median(serum)/me-
dian(Ccrcbrospinai nuid) of the average test value (see fig. 3).
l U = l μπιοί of Substrate hydrolysed per minute at
25 °C.
of healthy persons which were all of similar age. With
the exception of groups 5 and 8 (p lyneuropathy and ·
transitoric ischaemic attack, respectively), the various
groups show serum values below the detection limit,.
although this is less pronounced in groups 4 and 11
(inflammatory disease and miscellaneous diseases re-
spectively); compare table 1.
In all groups the median of cerebrospinal fluid values
is above the median of serum values.
Serum values showing the greatest deviation froin the
average value fall into two eategories: those below
the detection limit (17%), and thojse which are s high
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Fig. 3. Box- and Whisker-Plot of acetylcholinesterase measurements in serum and cerebrospinal fluid of 272 patients ordered in
13 diagnostic groups. Additionally there is one reference group of serum (healthy students) and one group of all values
measured in serum and cerebrospinal fluid. 272: all values of 272 patients, R: reference group serum, 1: epilepsy, 2: brain
haemorrhage, 3: tumours, 3: inflammatory diseases, 5: polyneuropathy, 6: disk protrusion, 7: multiple sclerosis, 8: transitoric
ischaemic attack, 9: brain infarction, 10: psychosis, 11: miscellaneous diseases, 12: bacterial meningitis, 13: viral meningitis.
The line crossing the rectangles represents the median or 50% of the measured values. The lower and upper limits of the
rectangles represent 25 or 75% of the values, respectively. The rectangle itself again represents 50% of the measured
values.
Hatched rectangles, serum; white rectangles, cerebrospinal fluid. l U = l μηιοί of Substrate hydrolysed per minute at
25 °C.
Tab. 1. Distribution of brain-barrier impairments, values below the detection limit in the serum, and serum values s high or
higher than the corresponding cerebrospinal fluid values among the diagnostic classes; n, number of patients studied; C,























































































































or even higher in serum than in cerebrospinal fluid of
the same person (20%). Most of these latter values
are in the high r nge in both compartments (> 10 U,
fig. 1). In table l, the percentage of blood-brain bar-
rier impairments per group is compared with the
percentage of values below the detection limit and
with the percentage of the values which are higher or
s high in serum s in cerebrospinal fluid. The data
from figure 3 is supplemented in various ways. Thus,
groups 12 and 13 (bacterial and viral meningitis re-
spectively, which are undoubtedly serious diseases
with decreased acetylcholinesterase levels in cerebro-
spinal fluid and serum) (fig. 3) show increased num-
bers of blood-brain barrier impairments and an in-
creased number of values below the detection limit in
the sera (tab. 1). Since, in addition to groups 12 and
13, high percentages of blood-brain barrier impair-
ments are also found in groups 6, 8, and 9 (disk
protrusion, transitoric ischaemic attack, and brain
infarction), there is no correlation between blood-
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brain barrier impairment and the values below the
detection limit. Serum values, which are äs high or
higher than the corresponding values of cerebrospinal
fluid, are more or less equally distributed throughout
the diagnostic groups, with the exception of group 2
(brain haemorrhage). Group 2, however, is one of the
two groups (2 and 8) with the smallest number of
cases.
Finally, groups 4 and 11 (inflammatory and miscel-
laneous diseases), which are the largest groups (52
and 57 cases, respectively), both show a very low
percentage of values below the detection limit (tab.
1). They show, however, widely varying elevated val-
ues of acetylcholinesterase in their cerebrospinal fluid,
and they include the highest values of all measured
in this study (fig. 3). These groups are the most
heterogeneous and they represent the more chronic
diseases. These two groups show average values of all
the other parameters studied (tab. 1).
Discussion
It has not been possible in the past to determine
reliably the amount of acetylcholinesterase present in
biological fluids, since there is neither a Substrate nor
an inhibitor absolutely specific for acetylcholinester-
ase or butyrylcholinesterase3) (9). Erroneous acetyl-
cholinesterase levels have been determined mainly in
the serum, which contains an overwhelming prepon-
derance of butyrylcholinesterase. In the present study,
an immunoassay was employed based on a mono-
clonal antibody selective for neuronal acetylcholin-
esterase (1). There was a slight cross-reactivity
(= 10%) with erythrocyte acetylcholinesterase (1).
Blood-contaminated cerebrospinal fluid samples,
however, did not show elevated acetylcholinesterase
levels, thus proving the reliability of the assay.
Eighty percent of the acetylcholinesterase levels de-
termined in the cerebrospinal fluid of 272 patients
with various neuropsychiatric disorders were higher
(1.5 — 10 fold) than the corresponding levels in the
sera. In addition to these results, the finding that
increasing serum values correspond to increasing cere-
brospinal fluid values (fig. 2) Supports the idea of a
brain to blood transfer of acetylcholinesterase. Fur-
ther evidence lends support to the above idea; thus
there were many values below the detection limit
(17%) in the patients' sera, while the corresponding
cerebrospinal fluid values were well above the detec-
tion limit and lay over a wide ränge. Finally, it is well
established that about 90% of the regulär cerebro-
spinal fluid protein originates from the serum (10). It
is therefore relevant to ask whether at least some part
of acetylcholinesterase in the cerebrospinal fluid may
originate from the serum. Neuronal acetylcholinester-
ase has a relative molecular mass of 290 000, corre-
sponding to a hydrodynamic radius of 5.8 nm (58 Ä)
(10). At the intact blood-cerebrospinal fluid barrier
the cerebrospinal fluid level would thus reach not
more than 0.1% of the serum level (100%). The
average cerebrospinal fluid level determined in this
study is, however, 4 fold (400%) that of the corre-
sponding serum level. Even in those cases (10%)
where the serum levels are above the cerebrospinal
fluid levels the latter are at least 50% of the serum
concenträtion. This by far exceeds the 0.1% cerebro-
spinal fluid concenträtion expected for a regulär
serum protein of the size of acetylcholinesterase.
Therefore it is justified to assume that the total
amount of acetylcholinesterase in the cerebrospinal
fluid originates from the nervous parenchyma of the
brain. Compared with the central nervous System, the
mass of cholinergic neurons in the periphefy is very
small indeed. Acetylcholinesterase is the second neu-
ronal enzyme to be described exhibiting cerebrospinal
fluid/serum rations > l (the first was neuron-specific
enolase (11)), suggesting that it originates in the brain.
Detection of brain-derived proteins in cerebrospinal
fluid and serum became possible only recently, with
the use of sensitive and selective immunoassays (9,
11, 12).
Due to the large Variation, a specific relatipnship of
acetylcholinesterase levels to any of the diagnostic
groups is not observed. Some trends are, however,
apparent. For example, the values measured in bac-
terial and viral meningitis (groups 12 and 13) com-
pared with the average of all values, indicate decreased
levels of acetylcholinesterase in cerebrospinal fluid
and serum and an increased percentage of values
below the detection limit, both possibly due to en-
hanced degradation of proteiiis in both compart-
ments. In cöntrast to these patients with the severe
diseases, the chronic inflammatory diseases (group 4)
display elevated levels of acetylcholinesterase in cere-
brospinal fluid and serum and only a very few values
below the detection limit. Most pf the diagnostic.
parameters (data not shown) determined in the cere-
brospinal fluid and serum of this latter group were
normal. Thus groups 4 and 11 (miscellaneous) might
both reflect a Situation close to normal with regard
to acetylcholinesterase levels, since they comprise
large numbers of patients and they do not represent
dramatic diseases.
The hope of finding diagnostically significänt altera^·
tions has, however, not yet been fulfilled and further
evaluation is necessary. The pr^sence of a possibly
Eur. J. Clin. Chem.· Clin. Bioehem. / Vol. 29,1991 / No. l
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brain-derived protein in the circulating blood, how-
ever, should encourage the search for markers of brain
destruction and disease which do not rely on lumbar
puncture alone.
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